0001658678 1 2026-10-05 2026-10-05 0001658678 2 2026-10-05 2026-10-05 0001658678 2026-10-05 2026-10-05 iso4217:USD pure shares S-8 EX-FILING FEES 0001658678 false false N/A S-8 BioStem Technologies, Inc. Equity Common Stock, par value $0.001 per share, to be offered under the 2022 Plan true 4071793 2.7041 11010535.45 0.000087 957.92 Equity Common Stock, par value $0.001 per share, offered for resale by selling stockholders true 5970627 2.7041 16145172.47 0.000087 1404.63 27155707.92 2362.55 2362.55 Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement (the “Registration Statement”) shall also cover any additional shares of Common Stock that become issuable under the Company’s 2022 Equity Incentive Plan (“2022 Plan”), 2021 Equity Incentive Plan, Matuszewski Options Agreement and Van Vurst Options Agreement, as a result of any stock dividend, stock split, recapitalization, or other similar transaction.<br/><br/>Calculated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(h) under the Securities Act. Pursuant to Rule 457(h) under the Securities Act, this price is calculated based on the average of the high and low of the Common Stock as reported on the Nasdaq Capital Market on October 5, 2026, which is within five business days prior to filing this Registration Statement. Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement (the “Registration Statement”) shall also cover any additional shares of Common Stock that become issuable under the Company’s 2022 Equity Incentive Plan (“2022 Plan”), 2021 Equity Incentive Plan, Matuszewski Options Agreement and Van Vurst Options Agreement, as a result of any stock dividend, stock split, recapitalization, or other similar transaction.<br/><br/>Calculated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) under the Securities Act. Pursuant to Rule 457(c) under the Securities Act, this price is calculated based on the average of the high and low of the Common Stock as reported on the Nasdaq Capital Market on October 5, 2026, which is within five business days prior to filing this Registration Statement.